Tag | Content |
---|
EnhancerAtlas ID | HS133-22701 |
Organism | Homo sapiens |
Tissue/cell | melanoma |
Coordinate | chr3:101592060-101592900 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
FOXP1 | MA0481.2 | chr3:101592621-101592633 | ATGTAAACAGAA | + | 6.92 | FOXP2 | MA0593.1 | chr3:101592621-101592632 | ATGTAAACAGA | + | 6.02 | NFAT5 | MA0606.1 | chr3:101592518-101592528 | ATTTTCCATT | + | 6.02 | NFATC1 | MA0624.1 | chr3:101592518-101592528 | ATTTTCCATT | + | 6.02 | NFATC3 | MA0625.1 | chr3:101592518-101592528 | ATTTTCCATT | + | 6.02 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_09392 | chr3:101591738-101593533 | CD14 | SE_59234 | chr3:101526313-101596096 | Ly3 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr3 | 101592355 | 101592794 | chr3 | 101592400 | 101592632 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH03I101873 | chr3 | 101592355 | 101592845 |
|
Enhancer Sequence | CTTGTCACTT TGGATTGGCC AAAACTTCAA TGTTCTTCAG CACTGTTTAA TGTCTACAAT 60 TGCTGTTCTG TACTTGTCTC TGCACTAACA CTTCTCTATA CTTACTATAA GACCCGGGTA 120 GTCTTGACAT GGGCACGTGC ACCTTAGCCC TGAGTCAAGA ATTCATAGAG AATCTTCCAT 180 ACAACTTCTG GGACCCACCT TCTCACCACC CCCAAAACAC CTTTCGTTTT GGTGCCTTGC 240 TCTACAGATT CTTCTGAACT CTTATCTCTG CCTTGTCAGC TCAGCAGAAC TACTGTGCTC 300 AGATTGGATT CTAGCTTGCT ATGCTGTGGT TGGAAAATTG TACCCTTGCA GAGATCCAGG 360 ATAATCATGG GCCTCACCTA ATGAATTTCT CCTCTCTCAG AGATCACAGT GTTTAATTTC 420 CTGTTGTCCA ATGCTGAAAA ACAATTGCCT CATATATTAT TTTCCATTTC ATTGTTTATG 480 GGTGGAGAGC TAGTCCTATA CCAGTTGTTT CATCATAGTT GGAAGTGAAA GTTTGCAAGA 540 TGTGTTCTTA AAGATTAAAT TATGTAAACA GAAACGGATT TACCAAAGAG GGGGCCCAAA 600 GATTCTGTTT GGGCTGAAAA AGCATTTATA ATAGTCATGA GTCCCATCCT ATGACTCAGA 660 CACTGACTCC ATTCATAGGA AGTTAGTATA GTGGAGTAGA GTGTAGTTTC TCTGCGTTAT 720 TTCTAAAAAT TGAGTCTAAC AGCCATCTCC CCTCTCTAGG AAACAAAAAG AAGGTTTCTA 780 AAAATAATAG TAGTAATAAT AACTTACTAT TATTATATAC TTAATGTTCT AGGTTCTGTC 840
|